Unraveling the Mystery: Mouth and Gut Bacteria as Allergy Defenders
The enigma of why individuals with similar peanut-specific antibodies exhibit varying allergic reactions has captivated researchers. A groundbreaking study, led by McMaster University scientists and published in Cell Host & Microbe, unveils a fascinating connection between gut bacteria and peanut allergy management.
The study, conducted on March 3, 2026, reveals that gut bacteria play a pivotal role in breaking down allergenic food components, potentially influencing allergic responses. This discovery holds promise for predicting and mitigating life-threatening anaphylaxis, a serious concern for peanut allergy sufferers.
Liam Rondeau, a postdoctoral fellow at McMaster University's Farncombe Family Digestive Health Research Institute, explains, "Peanut allergies can be severe, causing breathing difficulties and even posing a life-threatening risk. Interestingly, some individuals with peanut allergies can consume small amounts without adverse reactions. Our research focused on understanding why this occurs, and we made a remarkable discovery while studying oral microbes."
The researchers analyzed saliva and upper gut samples from healthy volunteers, identifying bacterial species capable of breaking down major peanut allergens. Among these, the Rothia species emerged as a standout, effectively reducing the binding of peanut proteins with antibodies, a key trigger for allergic reactions. The study further extended to individuals with peanut allergies, revealing that those with a higher abundance of allergen-degrading bacteria exhibited greater tolerance to peanuts before experiencing a reaction.
Co-senior author Alberto Caminero Fenandez, an associate professor at McMaster's Department of Medicine, highlights the significance of this finding: "Oral and gut microbes are essential for digestion. Our study provides evidence that specific microbes may aid in breaking down peanut components, potentially modulating allergic responses. This discovery opens a new avenue linking the oral and gut microbiome to food allergies, offering valuable insights for future research and treatment."
The research team's findings were further validated in an external dataset of 120 children, confirming the higher abundance of Rothia species in children with higher peanut reaction thresholds. Pre-clinical experiments demonstrated that Rothia reduced peanut allergens in the bloodstream, decreased immune cell activation, and resulted in milder allergic reactions upon exposure.
Peanut allergy, a prevalent condition among Canadian children, necessitates strict avoidance to prevent anaphylaxis. However, accidental exposures are common, affecting approximately one-third of affected children annually. Peanut allergy is the leading cause of allergy-related deaths in children.
This groundbreaking study paves the way for innovative allergy prevention and treatment strategies, including microbial and probiotic therapies, as well as enhanced oral immunotherapy approaches. The multicenter collaboration involved researchers from McMaster University, the Schroeder Allergy and Immunology Research Institute, and institutions in Spain and the United States.
Funding for this research was provided by various organizations, including the New Frontiers in Research Fund, Natural Sciences and Engineering Research Council of Canada, Farncombe Institute, Nutricia Research Foundation, European Food Safety Authority, Spanish government programs, Instituto de Salud Carlos III, Canadian Institutes of Health Research, Crohn's and Colitis Canada, and the Community of Madrid.
